Jump to content
  • Sign Up
Celiac.com Sponsor:


Celiac.com Sponsor:


  • Join Our Community!

    Get help in our celiac / gluten-free forum.

  • Jefferson Adams

    What's the Significance of Reduced Serum Immunoglobulin G Concentrations in Multiple Sclerosis?

    Jefferson Adams


    Reviewed and edited by a celiac disease expert.

      In patients with celiac disease Ig deficiency affects 1.7% of patients.


    Caption: Trussed. Image: CC BY 2.0--Nicholas_T

    Celiac.com 01/08/2020 - Researchers currently don't have much good information on the frequency of hypogammaglobulinemia (Ig deficiency) in people with multiple sclerosis. A team of researchers recently set out to assess the frequency of reduced immunoglobulin (Ig) concentrations and its association with immunotherapy and disease course in two independent multiple sclerosis study groups.

    The research team included Greta Zoehner, Andrei Miclea, Anke Salmen, Nicole Kamber, Lara Diem, Christoph Friedli, Maud Bagnoud, Farhad Ahmadi, Myriam Briner, Nazanin Sédille-Mostafaie, Constantinos Kilidireas, Leonidas Stefanis, Andrew Chan, Robert Hoepner, and Maria Eleftheria Evangelopoulos.



    Celiac.com Sponsor:




    The team's retrospective cross-sectional study included multiple sclerosis patients and control patients with head or neck pain from Bern University Hospital in Bern, and Eginition University Hospital in Athens. 

    The lower limits of normal (LLN) for serum Ig concentration were IgG < 700 mg/dl, IgM < 40 mg/dl, and IgA < 70 mg/dl. The team analyzed the results using the Mann–Whitney U test, analysis of variance test, and multiple linear regression.

    The study shows that multiple sclerosis patients have high rates of reduced serum IgG concentrations, both with and without disease-modifying treatments.  Interestingly, in patients with other autoimmune diseases, Ig deficiency is also more prevalent, and 1.7% of patients with celiac disease and 5.2% of patients with systemic lupus erythematosus also have IgA deficiency.

    Given that infections or interference with antibody production usually happen at much lower IgG levels, around 400 mg/dl, and below, the importance of lower IgG concentrations at the levels noted remains unknown.

    The team suggests using the information to monitor IgG levels, particularly with anti-B-cell therapies, and considering IgG substitution at levels below 400 mg/dl.

    Read more in Therapeutic Advances in Neurological Disorders

     

    The researchers are variously affiliated with the Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; the University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; the Center of Laboratory Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; the Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; and the Department of Neurology, Eginition University Hospital at the National and Kapodistrian University of Athens, Athens, Greece.


    User Feedback

    Recommended Comments

    There are no comments to display.



    Join the conversation

    You are posting as a guest. If you have an account, sign in now to post with your account.
    Note: Your post will require moderator approval before it will be visible.

    Guest
    Add a comment...

    ×   Pasted as rich text.   Paste as plain text instead

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.


  • About Me

    Jefferson Adams is Celiac.com's senior writer and Digital Content Director. He earned his B.A. and M.F.A. at Arizona State University, and has authored more than 2,500 articles on celiac disease. His coursework includes studies in science, scientific methodology, biology, anatomy, medicine, logic, and advanced research. He previously served as SF Health News Examiner for Examiner.com, and devised health and medical content for Sharecare.com. Jefferson has spoken about celiac disease to the media, including an appearance on the KQED radio show Forum, and is the editor of the book "Cereal Killers" by Scott Adams and Ron Hoggan, Ed.D.

  • Related Articles

    Jefferson Adams
    Celiac.com 05/11/2011 - People with multiple sclerosis and their first-generation relatives have higher rates of celiac disease than the general population, according to a report by a research team in Spain.
    For the study, a research team led by Dr. Luis Rodrigo of University Hospital, Central Asturias, Spain looked at rates of serological, genetic, and histological disease...

    Jefferson Adams
    Celiac.com 08/30/2017 - The human gut is home to a huge and diverse number of microorganisms that perform various biological roles. Disturbances in a healthy gut microbiome might help to trigger various inflammatory diseases, such as multiple sclerosis (MS).
    Human gut-derived commensal bacteria suppress CNS inflammatory and demyelinating disease. Can they improve the treatment...

    Jefferson Adams
    Celiac.com 03/25/2019 - Some researchers have suspected that myelin proteins may be involved in multiple sclerosis (MS). A recent report in Science and Translational Medicine, suggests that additional non-myelin-related protein may also play a role. Researchers examined protein samples from the brains of 31 people who had died from suspected or confirmed MS. They found that T cells...

  • Celiac.com Sponsor:

  • Forum Discussions

    I am not sure what you mean by "The Nima device has many issues" as the device very accurately measures whatever you put into it. The issue is not the device, but perhaps the possibility that some of the food you didn't put into the test has...
    Also, the same logic people use against using enzymes could be applied to the Nima device. The Nima device has many issues and you are still possibly being exposed to gluten. Like enyzmes, the Nima device doesn't replace properly implementing...
    Personallyu Well, actually there are plenty of studies showing the ingredients in GliadinX in fact does break down gluten by 50-85% before it reaches the small intestine. I believe the reason Scott recommends using it when you are ...
×
×
  • Create New...